Objective: from December 1993 until January 1996 rye observed 10 cases
of invasive aspergillosis in a cohort of 140 patients with AIDS (7%),
By contrast, no invasive aspergillosis was diagnosed in a cohort of 2
78 patients with AIDS between 1986 until 1993. Methods: case controls
were assigned randomly to each patient with invasive aspergillosis fro
m the total pool of HIV-infected patients. Patients with invasive aspe
rgillosis were studied retrospectively by matched-pairs analysis with
respect to risk factors, radiological, microbiological and autopsy fin
dings. Results: patients with aspergillosis had more AIDS-defining eve
nts (3.5 [2-5] vs. 2 [2-3], median [range], P<0.05) and a longer media
n survival time with full-blown AIDS (31.5 [14-45] months vs. 20.5 [5-
32] months, P<0.005) than their case controls. Patients with invasive
aspergillosis tended to have lower white blood cell counts and exhibit
ed significantly decreased median CD4 counts (7 [0-44]/mm(3) vs. 27 [8
-57]/mm(3), P<0.05). Conclusions: due to better management of opportun
istic diseases and improved antiretroviral therapy, the lifespan of pa
tients with full blown AIDS is prolonged, Patients who have survived f
our or more AIDS-defining events are at risk for invasive aspergillosi
s. This risk is associated with low white blood cell counts and CD4 ce
ll counts.